

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.54618068 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.50778052 |
| 3 | response to interferon-beta (GO:0035456) | 4.23068019 |
| 4 | iron-sulfur cluster assembly (GO:0016226) | 4.15726927 |
| 5 | metallo-sulfur cluster assembly (GO:0031163) | 4.15726927 |
| 6 | DNA deamination (GO:0045006) | 4.11393316 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05876441 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.05876441 |
| 9 | cellular response to interferon-beta (GO:0035458) | 3.98664719 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 3.97375079 |
| 11 | histone H2A acetylation (GO:0043968) | 3.91560547 |
| 12 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.91392086 |
| 13 | synaptonemal complex assembly (GO:0007130) | 3.82159319 |
| 14 | positive thymic T cell selection (GO:0045059) | 3.77524986 |
| 15 | GDP-mannose metabolic process (GO:0019673) | 3.74986139 |
| 16 | IMP biosynthetic process (GO:0006188) | 3.73156413 |
| 17 | histone H4-K12 acetylation (GO:0043983) | 3.70750012 |
| 18 | actin nucleation (GO:0045010) | 3.69457910 |
| 19 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.68864412 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.66409760 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66310045 |
| 22 | cytidine catabolic process (GO:0006216) | 3.65896973 |
| 23 | cytidine deamination (GO:0009972) | 3.65896973 |
| 24 | cytidine metabolic process (GO:0046087) | 3.65896973 |
| 25 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.65306606 |
| 26 | nucleobase biosynthetic process (GO:0046112) | 3.59753717 |
| 27 | protein insertion into membrane (GO:0051205) | 3.50979198 |
| 28 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48609559 |
| 29 | synaptonemal complex organization (GO:0070193) | 3.48452789 |
| 30 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.45854138 |
| 31 | ribosome biogenesis (GO:0042254) | 3.43559816 |
| 32 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.43241906 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.39241084 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 3.39241084 |
| 35 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.39140187 |
| 36 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.38763423 |
| 37 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.38426311 |
| 38 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.37879479 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.35361026 |
| 40 | DNA unwinding involved in DNA replication (GO:0006268) | 3.31390615 |
| 41 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.31199922 |
| 42 | mitochondrion transport along microtubule (GO:0047497) | 3.31199922 |
| 43 | regulation of translational fidelity (GO:0006450) | 3.29503449 |
| 44 | purine nucleobase biosynthetic process (GO:0009113) | 3.28983415 |
| 45 | establishment of mitochondrion localization (GO:0051654) | 3.28166660 |
| 46 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.27462331 |
| 47 | negative regulation of B cell apoptotic process (GO:0002903) | 3.26144016 |
| 48 | nucleotide salvage (GO:0043173) | 3.26124912 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 3.25167757 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25067496 |
| 51 | pre-miRNA processing (GO:0031054) | 3.24483638 |
| 52 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.23923689 |
| 53 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.23923689 |
| 54 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.23080370 |
| 55 | DNA replication initiation (GO:0006270) | 3.22842972 |
| 56 | mitotic nuclear envelope disassembly (GO:0007077) | 3.22186672 |
| 57 | histone arginine methylation (GO:0034969) | 3.21128956 |
| 58 | postreplication repair (GO:0006301) | 3.20083436 |
| 59 | mitotic G1/S transition checkpoint (GO:0044819) | 3.19953046 |
| 60 | protein localization to kinetochore (GO:0034501) | 3.18772977 |
| 61 | protein localization to chromosome, centromeric region (GO:0071459) | 3.18174512 |
| 62 | viral transcription (GO:0019083) | 3.17993925 |
| 63 | maturation of SSU-rRNA (GO:0030490) | 3.16864108 |
| 64 | DNA strand elongation (GO:0022616) | 3.15957175 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.14222189 |
| 66 | IMP metabolic process (GO:0046040) | 3.14123566 |
| 67 | protein-DNA complex disassembly (GO:0032986) | 3.12981081 |
| 68 | nucleosome disassembly (GO:0006337) | 3.12981081 |
| 69 | translesion synthesis (GO:0019985) | 3.12636675 |
| 70 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.12217742 |
| 71 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.12217742 |
| 72 | mitotic sister chromatid segregation (GO:0000070) | 3.11475823 |
| 73 | negative regulation of telomere maintenance (GO:0032205) | 3.10117556 |
| 74 | positive regulation of T cell apoptotic process (GO:0070234) | 3.09137093 |
| 75 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 3.08981644 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08338696 |
| 77 | regulation of translational termination (GO:0006449) | 3.08060883 |
| 78 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.07093056 |
| 79 | thymic T cell selection (GO:0045061) | 3.06001283 |
| 80 | UV protection (GO:0009650) | 3.05588028 |
| 81 | G1 DNA damage checkpoint (GO:0044783) | 3.03750969 |
| 82 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.03574610 |
| 83 | heterochromatin organization (GO:0070828) | 3.03016811 |
| 84 | T cell migration (GO:0072678) | 3.02931033 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.01701061 |
| 86 | peptidyl-arginine methylation (GO:0018216) | 3.01659672 |
| 87 | peptidyl-arginine N-methylation (GO:0035246) | 3.01659672 |
| 88 | pyrimidine dimer repair (GO:0006290) | 3.01604982 |
| 89 | base-excision repair, AP site formation (GO:0006285) | 3.00798723 |
| 90 | nuclear envelope disassembly (GO:0051081) | 2.99704697 |
| 91 | membrane disassembly (GO:0030397) | 2.99704697 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98715948 |
| 93 | deoxyribonucleotide catabolic process (GO:0009264) | 2.98534836 |
| 94 | negative thymic T cell selection (GO:0045060) | 2.96447405 |
| 95 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94690333 |
| 96 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94690333 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.94569322 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.94080164 |
| 99 | * mRNA splicing, via spliceosome (GO:0000398) | 2.93190549 |
| 100 | * RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.93190549 |
| 101 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.92855502 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92484197 |
| 103 | * RNA splicing, via transesterification reactions (GO:0000375) | 2.92084478 |
| 104 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.91529746 |
| 105 | mitotic metaphase plate congression (GO:0007080) | 2.91284788 |
| 106 | modulation by virus of host process (GO:0019054) | 2.91160344 |
| 107 | pentose metabolic process (GO:0019321) | 2.90586835 |
| 108 | deoxyribose phosphate catabolic process (GO:0046386) | 2.90478501 |
| 109 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.89083527 |
| 110 | ncRNA 3-end processing (GO:0043628) | 2.88926286 |
| 111 | cellular response to virus (GO:0098586) | 2.88678076 |
| 112 | tRNA aminoacylation for protein translation (GO:0006418) | 2.88090041 |
| 113 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87956222 |
| 114 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87956222 |
| 115 | modulation by symbiont of host immune response (GO:0052553) | 2.87956222 |
| 116 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87956222 |
| 117 | modulation by symbiont of host defense response (GO:0052031) | 2.87956222 |
| 118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87956222 |
| 119 | negative T cell selection (GO:0043383) | 2.87438350 |
| 120 | male meiosis (GO:0007140) | 2.86935166 |
| 121 | histone H4-K5 acetylation (GO:0043981) | 2.85859619 |
| 122 | histone H4-K8 acetylation (GO:0043982) | 2.85859619 |
| 123 | peptidyl-arginine modification (GO:0018195) | 2.85730928 |
| 124 | DNA replication checkpoint (GO:0000076) | 2.85653110 |
| 125 | tRNA aminoacylation (GO:0043039) | 2.83509755 |
| 126 | amino acid activation (GO:0043038) | 2.83509755 |
| 127 | nuclear pore organization (GO:0006999) | 2.83184539 |
| 128 | protein retention in ER lumen (GO:0006621) | 2.82541647 |
| 129 | negative regulation of type 2 immune response (GO:0002829) | 2.82265706 |
| 130 | negative regulation of RNA splicing (GO:0033119) | 2.82211810 |
| 131 | chromatin silencing (GO:0006342) | 2.81842245 |
| 132 | negative regulation of mRNA metabolic process (GO:1903312) | 2.81578052 |
| 133 | nodal signaling pathway (GO:0038092) | 2.80444654 |
| 134 | leukocyte aggregation (GO:0070486) | 2.80113714 |
| 135 | dosage compensation (GO:0007549) | 2.79433785 |
| 136 | translational termination (GO:0006415) | 2.77654202 |
| 137 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.77504902 |
| 138 | protein complex localization (GO:0031503) | 2.76394207 |
| 139 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76324457 |
| 140 | negative regulation of mRNA processing (GO:0050686) | 2.75092080 |
| 141 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.73910204 |
| 142 | translational elongation (GO:0006414) | 2.73690245 |
| 143 | meiosis I (GO:0007127) | 2.72701239 |
| 144 | sister chromatid segregation (GO:0000819) | 2.72013091 |
| 145 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70476217 |
| 146 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.69562608 |
| 147 | Peyers patch development (GO:0048541) | 2.69562608 |
| 148 | negative regulation of necroptotic process (GO:0060546) | 2.69009087 |
| 149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68116129 |
| 150 | positive regulation of synapse maturation (GO:0090129) | 2.67847186 |
| 151 | piRNA metabolic process (GO:0034587) | 2.67092364 |
| 152 | spliceosomal snRNP assembly (GO:0000387) | 2.66530053 |
| 153 | snRNA processing (GO:0016180) | 2.66131063 |
| 154 | regulation of DNA damage checkpoint (GO:2000001) | 2.65847905 |
| 155 | chaperone-mediated protein complex assembly (GO:0051131) | 2.65133587 |
| 156 | meiotic nuclear division (GO:0007126) | 2.65074992 |
| 157 | ribosome assembly (GO:0042255) | 2.64968005 |
| 158 | purine nucleotide salvage (GO:0032261) | 2.64592821 |
| 159 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63735859 |
| 160 | regulation of B cell differentiation (GO:0045577) | 2.62666785 |
| 161 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.62304985 |
| 162 | regulation of chromatin binding (GO:0035561) | 2.61659529 |
| 163 | DNA duplex unwinding (GO:0032508) | 2.60589089 |
| 164 | negative regulation of chromosome segregation (GO:0051985) | 2.59833725 |
| 165 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.59740751 |
| 166 | respiratory burst (GO:0045730) | 2.59620817 |
| 167 | negative regulation of translational initiation (GO:0045947) | 2.59607450 |
| 168 | sequestering of actin monomers (GO:0042989) | 2.58657099 |
| 169 | gene silencing (GO:0016458) | 2.58635106 |
| 170 | snRNA metabolic process (GO:0016073) | 2.58488965 |
| 171 | negative regulation of interleukin-12 production (GO:0032695) | 2.57974544 |
| 172 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.57389604 |
| 173 | mitotic chromosome condensation (GO:0007076) | 2.57022535 |
| 174 | DNA geometric change (GO:0032392) | 2.56045122 |
| 175 | regulation of chromosome segregation (GO:0051983) | 2.55855634 |
| 176 | viral life cycle (GO:0019058) | 2.55060543 |
| 177 | rRNA processing (GO:0006364) | 2.54416151 |
| 178 | negative regulation of innate immune response (GO:0045824) | 2.54086504 |
| 179 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.53338359 |
| 180 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.53338359 |
| 181 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.53338359 |
| 182 | negative regulation of sister chromatid segregation (GO:0033046) | 2.53338359 |
| 183 | negative regulation of histone methylation (GO:0031061) | 2.52672332 |
| 184 | rRNA metabolic process (GO:0016072) | 2.51741798 |
| 185 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) | 2.51682190 |
| 186 | T cell selection (GO:0045058) | 2.51280831 |
| 187 | cellular response to interleukin-4 (GO:0071353) | 2.51248540 |
| 188 | positive T cell selection (GO:0043368) | 2.51030290 |
| 189 | activation of MAPKKK activity (GO:0000185) | 2.51006769 |
| 190 | positive regulation of defense response to virus by host (GO:0002230) | 2.48344037 |
| 191 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.48306253 |
| 192 | type I interferon signaling pathway (GO:0060337) | 2.46903431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.64964742 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57777147 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.34760420 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.32668909 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.86585433 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.73094861 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68221557 |
| 8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.64489546 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37311463 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.37030662 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.33684813 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33060966 |
| 13 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.29702069 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27379626 |
| 15 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.27203837 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.23375314 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.16359537 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.10792585 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.10148296 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05084904 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02923928 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.02922819 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02423839 |
| 24 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.88597303 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88391960 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 1.87993486 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86030619 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.84279940 |
| 29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84159601 |
| 30 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.79741897 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79128151 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.78433735 |
| 33 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.76360543 |
| 34 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.73612761 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73566372 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70835197 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68263257 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.67998031 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64986613 |
| 40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63868802 |
| 41 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62934922 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61951003 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61949803 |
| 44 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.61924419 |
| 45 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.60719391 |
| 46 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.59980163 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58672512 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55512886 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55433893 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55029452 |
| 51 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.54574621 |
| 52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54099065 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54021769 |
| 54 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.53406253 |
| 55 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53356086 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53102515 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51567761 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49040115 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48894787 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48793023 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47640433 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47398311 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44245936 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.43179971 |
| 65 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.42753907 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41910446 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41640171 |
| 68 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39922877 |
| 69 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.39622199 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.36773742 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35958367 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 1.35847252 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32781644 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32766252 |
| 75 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.32758980 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31815197 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31794799 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30865212 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29654781 |
| 80 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.29491340 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28914665 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.27657743 |
| 83 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26817906 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26581377 |
| 85 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26342902 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25891283 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24958566 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24757405 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24209573 |
| 90 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23747858 |
| 91 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23659257 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23613041 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23205235 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22503819 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21118147 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20980139 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 1.19681486 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19549242 |
| 99 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.19428827 |
| 100 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.19389153 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17026929 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16749721 |
| 103 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16377151 |
| 104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14088985 |
| 105 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.14065787 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13901472 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13756404 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13125703 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13044055 |
| 110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12258062 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12139203 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11857837 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11342569 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11023836 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10986489 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10416022 |
| 117 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10369511 |
| 118 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10196712 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10125339 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09980395 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09514671 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09449838 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09159415 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07964366 |
| 125 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07906622 |
| 126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07663917 |
| 127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07389982 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07147285 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07005019 |
| 130 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.06959857 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06802080 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06658051 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06061061 |
| 134 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05625393 |
| 135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05270796 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03791441 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03775869 |
| 138 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03349071 |
| 139 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03308211 |
| 140 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00292824 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.98305259 |
| 142 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97598063 |
| 143 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96916967 |
| 144 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96830145 |
| 145 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94591764 |
| 146 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93905104 |
| 147 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93676195 |
| 148 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93114382 |
| 149 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91584416 |
| 150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89311009 |
| 151 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88889739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.15516192 |
| 2 | MP0005671_abnormal_response_to | 3.85941681 |
| 3 | MP0008877_abnormal_DNA_methylation | 3.72536211 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.59122881 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.45371389 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.24678267 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.23147648 |
| 8 | MP0003436_decreased_susceptibility_to | 3.22615171 |
| 9 | MP0003077_abnormal_cell_cycle | 2.85290062 |
| 10 | MP0003283_abnormal_digestive_organ | 2.76451673 |
| 11 | MP0004233_abnormal_muscle_weight | 2.65705261 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.54460551 |
| 13 | MP0008058_abnormal_DNA_repair | 2.47217667 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.47142117 |
| 15 | MP0005025_abnormal_response_to | 2.44017124 |
| 16 | MP0009785_altered_susceptibility_to | 2.35687986 |
| 17 | MP0003303_peritoneal_inflammation | 2.34910046 |
| 18 | MP0001730_embryonic_growth_arrest | 2.33701679 |
| 19 | MP0000685_abnormal_immune_system | 2.32726794 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.29841621 |
| 21 | MP0005451_abnormal_body_composition | 2.24506321 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.22975801 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.21315455 |
| 24 | MP0001819_abnormal_immune_cell | 2.18395288 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.18215940 |
| 26 | MP0002723_abnormal_immune_serum | 2.15083703 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.12450615 |
| 28 | MP0001800_abnormal_humoral_immune | 2.12190485 |
| 29 | MP0002419_abnormal_innate_immunity | 2.00935230 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.95119818 |
| 31 | MP0000350_abnormal_cell_proliferation | 1.94199875 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.93683308 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.93370133 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.92735475 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.89950564 |
| 36 | MP0001790_abnormal_immune_system | 1.89327615 |
| 37 | MP0005387_immune_system_phenotype | 1.89327615 |
| 38 | MP0002234_abnormal_pharynx_morphology | 1.83046494 |
| 39 | MP0000716_abnormal_immune_system | 1.82573399 |
| 40 | MP0003123_paternal_imprinting | 1.78748538 |
| 41 | MP0008057_abnormal_DNA_replication | 1.78237237 |
| 42 | MP0005394_taste/olfaction_phenotype | 1.75390785 |
| 43 | MP0005499_abnormal_olfactory_system | 1.75390785 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.73451321 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.70326239 |
| 46 | MP0005410_abnormal_fertilization | 1.67267556 |
| 47 | MP0001697_abnormal_embryo_size | 1.64578154 |
| 48 | MP0004858_abnormal_nervous_system | 1.63788365 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.61741883 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.60245132 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.58996153 |
| 52 | MP0001672_abnormal_embryogenesis/_devel | 1.58809369 |
| 53 | MP0005380_embryogenesis_phenotype | 1.58809369 |
| 54 | MP0002429_abnormal_blood_cell | 1.57345524 |
| 55 | MP0001929_abnormal_gametogenesis | 1.56692410 |
| 56 | MP0009840_abnormal_foam_cell | 1.55862814 |
| 57 | MP0004133_heterotaxia | 1.55113393 |
| 58 | MP0002084_abnormal_developmental_patter | 1.55093628 |
| 59 | MP0002080_prenatal_lethality | 1.54454921 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.52752985 |
| 61 | MP0003984_embryonic_growth_retardation | 1.51305020 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.51283261 |
| 63 | MP0010307_abnormal_tumor_latency | 1.49102736 |
| 64 | MP0002085_abnormal_embryonic_tissue | 1.48909136 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.47137718 |
| 66 | MP0003329_amyloid_beta_deposits | 1.46834755 |
| 67 | MP0002210_abnormal_sex_determination | 1.46530532 |
| 68 | MP0003890_abnormal_embryonic-extraembry | 1.45711627 |
| 69 | MP0003786_premature_aging | 1.45499238 |
| 70 | MP0006082_CNS_inflammation | 1.45253372 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.45160854 |
| 72 | MP0003787_abnormal_imprinting | 1.44634271 |
| 73 | MP0000313_abnormal_cell_death | 1.44337400 |
| 74 | MP0003119_abnormal_digestive_system | 1.43735707 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.43615671 |
| 76 | MP0003698_abnormal_male_reproductive | 1.43352850 |
| 77 | MP0002822_catalepsy | 1.43000528 |
| 78 | MP0003646_muscle_fatigue | 1.38458262 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.38277633 |
| 80 | MP0001145_abnormal_male_reproductive | 1.37029416 |
| 81 | MP0002405_respiratory_system_inflammati | 1.36285372 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 1.35147117 |
| 83 | MP0009764_decreased_sensitivity_to | 1.35092898 |
| 84 | MP0000490_abnormal_crypts_of | 1.30082486 |
| 85 | MP0008260_abnormal_autophagy | 1.28783898 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 1.28659110 |
| 87 | MP0003121_genomic_imprinting | 1.27227724 |
| 88 | MP0001905_abnormal_dopamine_level | 1.26726273 |
| 89 | MP0003724_increased_susceptibility_to | 1.25307573 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.25283494 |
| 91 | MP0002269_muscular_atrophy | 1.23996448 |
| 92 | MP0000703_abnormal_thymus_morphology | 1.23590984 |
| 93 | MP0009278_abnormal_bone_marrow | 1.23301837 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.21522803 |
| 95 | MP0004142_abnormal_muscle_tone | 1.20574770 |
| 96 | MP0004197_abnormal_fetal_growth/weight/ | 1.18684335 |
| 97 | MP0008469_abnormal_protein_level | 1.16275099 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 1.13416489 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 1.10767700 |
| 100 | MP0001849_ear_inflammation | 1.10504891 |
| 101 | MP0005023_abnormal_wound_healing | 1.09487319 |
| 102 | MP0000358_abnormal_cell_content/ | 1.09001680 |
| 103 | MP0000653_abnormal_sex_gland | 1.05032695 |
| 104 | MP0002160_abnormal_reproductive_system | 1.05031103 |
| 105 | MP0002019_abnormal_tumor_incidence | 1.04342213 |
| 106 | MP0005670_abnormal_white_adipose | 1.02631186 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 1.01164295 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.99847250 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.99847250 |
| 110 | MP0000343_altered_response_to | 0.99837529 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98400207 |
| 112 | MP0009672_abnormal_birth_weight | 0.98291233 |
| 113 | MP0001348_abnormal_lacrimal_gland | 0.97280728 |
| 114 | MP0004947_skin_inflammation | 0.95473041 |
| 115 | MP0002161_abnormal_fertility/fecundity | 0.95294154 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.92918228 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.92895048 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.92868432 |
| 119 | MP0000750_abnormal_muscle_regeneration | 0.91263023 |
| 120 | MP0005384_cellular_phenotype | 0.90510198 |
| 121 | MP0000049_abnormal_middle_ear | 0.87210967 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.87190125 |
| 123 | MP0000604_amyloidosis | 0.86548920 |
| 124 | MP0003763_abnormal_thymus_physiology | 0.86258660 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.85942403 |
| 126 | MP0002254_reproductive_system_inflammat | 0.83802309 |
| 127 | MP0008872_abnormal_physiological_respon | 0.82830774 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.82467023 |
| 129 | MP0005621_abnormal_cell_physiology | 0.82439886 |
| 130 | MP0003075_altered_response_to | 0.81840322 |
| 131 | MP0000537_abnormal_urethra_morphology | 0.80938504 |
| 132 | MP0004859_abnormal_synaptic_plasticity | 0.80909224 |
| 133 | MP0000534_abnormal_ureter_morphology | 0.80162816 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.79601615 |
| 135 | MP0008770_decreased_survivor_rate | 0.79040639 |
| 136 | MP0003705_abnormal_hypodermis_morpholog | 0.78721179 |
| 137 | MP0003938_abnormal_ear_development | 0.78475867 |
| 138 | MP0000858_altered_metastatic_potential | 0.76567730 |
| 139 | MP0002933_joint_inflammation | 0.76284160 |
| 140 | MP0001873_stomach_inflammation | 0.76118227 |
| 141 | MP0001293_anophthalmia | 0.75878454 |
| 142 | MP0003861_abnormal_nervous_system | 0.75714992 |
| 143 | MP0002909_abnormal_adrenal_gland | 0.74774339 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.73804365 |
| 145 | MP0002277_abnormal_respiratory_mucosa | 0.73646264 |
| 146 | MP0000751_myopathy | 0.73555349 |
| 147 | MP0004811_abnormal_neuron_physiology | 0.72883910 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.72560621 |
| 149 | MP0002877_abnormal_melanocyte_morpholog | 0.71498095 |
| 150 | MP0002398_abnormal_bone_marrow | 0.71410761 |
| 151 | MP0008874_decreased_physiological_sensi | 0.71379198 |
| 152 | MP0001502_abnormal_circadian_rhythm | 0.70665873 |
| 153 | MP0001663_abnormal_digestive_system | 0.70595491 |
| 154 | MP0009703_decreased_birth_body | 0.70520645 |
| 155 | MP0009333_abnormal_splenocyte_physiolog | 0.70299243 |
| 156 | MP0009763_increased_sensitivity_to | 0.70045082 |
| 157 | MP0002064_seizures | 0.69288986 |
| 158 | MP0005390_skeleton_phenotype | 0.68972476 |
| 159 | MP0000003_abnormal_adipose_tissue | 0.67830608 |
| 160 | MP0003115_abnormal_respiratory_system | 0.67707360 |
| 161 | MP0000015_abnormal_ear_pigmentation | 0.67322119 |
| 162 | MP0002722_abnormal_immune_system | 0.66701776 |
| 163 | MP0001529_abnormal_vocalization | 0.65476781 |
| 164 | MP0002249_abnormal_larynx_morphology | 0.65087773 |
| 165 | MP0005377_hearing/vestibular/ear_phenot | 0.64415671 |
| 166 | MP0003866_abnormal_defecation | 0.64196604 |
| 167 | MP0000747_muscle_weakness | 0.62951095 |
| 168 | MP0002083_premature_death | 0.60773194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ependymoma (HP:0002888) | 4.88598068 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 4.00483180 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.88328538 |
| 4 | Carpal bone hypoplasia (HP:0001498) | 3.76164972 |
| 5 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63290111 |
| 6 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63290111 |
| 7 | Increased muscle lipid content (HP:0009058) | 3.61204500 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.47483016 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47134306 |
| 10 | Obstructive lung disease (HP:0006536) | 3.47134306 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.44545001 |
| 12 | Hyperacusis (HP:0010780) | 3.33579944 |
| 13 | Abnormality of the astrocytes (HP:0100707) | 3.29618638 |
| 14 | Astrocytoma (HP:0009592) | 3.29618638 |
| 15 | Myositis (HP:0100614) | 3.27176481 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.16957463 |
| 17 | Abnormality of the anterior horn cell (HP:0006802) | 3.15339804 |
| 18 | Degeneration of anterior horn cells (HP:0002398) | 3.15339804 |
| 19 | Medulloblastoma (HP:0002885) | 2.99544183 |
| 20 | Biliary tract neoplasm (HP:0100574) | 2.93128777 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.86398419 |
| 22 | Glioma (HP:0009733) | 2.83740238 |
| 23 | Microvesicular hepatic steatosis (HP:0001414) | 2.83422719 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82691396 |
| 25 | Orchitis (HP:0100796) | 2.82166666 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.81772346 |
| 27 | Hand muscle atrophy (HP:0009130) | 2.80097345 |
| 28 | Visual hallucinations (HP:0002367) | 2.78411784 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 2.78254571 |
| 30 | Neoplasm of the pancreas (HP:0002894) | 2.74706002 |
| 31 | Cerebral hypomyelination (HP:0006808) | 2.72670333 |
| 32 | Insomnia (HP:0100785) | 2.71316985 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.70663239 |
| 34 | Selective tooth agenesis (HP:0001592) | 2.69088666 |
| 35 | Meningitis (HP:0001287) | 2.68040054 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 2.67516267 |
| 37 | Hypertensive crisis (HP:0100735) | 2.66960583 |
| 38 | Myopathic facies (HP:0002058) | 2.65065288 |
| 39 | Hepatocellular necrosis (HP:0001404) | 2.64787317 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.62748627 |
| 41 | Encephalitis (HP:0002383) | 2.62232335 |
| 42 | Hypoplasia of the pons (HP:0012110) | 2.60828474 |
| 43 | Stomatitis (HP:0010280) | 2.60587085 |
| 44 | Patellar aplasia (HP:0006443) | 2.60492678 |
| 45 | Trismus (HP:0000211) | 2.60379444 |
| 46 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.60173514 |
| 47 | Birth length less than 3rd percentile (HP:0003561) | 2.59033218 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.57208200 |
| 49 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.55426519 |
| 50 | Increased IgE level (HP:0003212) | 2.53608766 |
| 51 | Recurrent skin infections (HP:0001581) | 2.52137368 |
| 52 | Spinal muscular atrophy (HP:0007269) | 2.51090015 |
| 53 | Poikiloderma (HP:0001029) | 2.50422451 |
| 54 | Thrombocytosis (HP:0001894) | 2.49312611 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.44698302 |
| 56 | Basal cell carcinoma (HP:0002671) | 2.43539539 |
| 57 | IgG deficiency (HP:0004315) | 2.43477277 |
| 58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.43052675 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.41010695 |
| 60 | Increased nuchal translucency (HP:0010880) | 2.40971611 |
| 61 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.40825770 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.40669510 |
| 63 | Upper limb amyotrophy (HP:0009129) | 2.40669510 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.40151990 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.39953545 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.39586482 |
| 67 | Entropion (HP:0000621) | 2.38352260 |
| 68 | Colon cancer (HP:0003003) | 2.37330039 |
| 69 | Aplastic anemia (HP:0001915) | 2.35899371 |
| 70 | Renal duplication (HP:0000075) | 2.34539086 |
| 71 | Retinal dysplasia (HP:0007973) | 2.34356938 |
| 72 | Petechiae (HP:0000967) | 2.33089102 |
| 73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31077967 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31077967 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.27505278 |
| 76 | Abnormal number of incisors (HP:0011064) | 2.27191620 |
| 77 | Combined immunodeficiency (HP:0005387) | 2.26550942 |
| 78 | Pelvic girdle muscle weakness (HP:0003749) | 2.25835255 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.22702685 |
| 80 | Abnormality of the labia minora (HP:0012880) | 2.21601795 |
| 81 | Peripheral hypomyelination (HP:0007182) | 2.20046087 |
| 82 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.19530189 |
| 83 | Retrobulbar optic neuritis (HP:0100654) | 2.18979901 |
| 84 | Optic neuritis (HP:0100653) | 2.18979901 |
| 85 | Broad distal phalanx of finger (HP:0009836) | 2.18960197 |
| 86 | Hepatic necrosis (HP:0002605) | 2.17593227 |
| 87 | Neoplasm of the heart (HP:0100544) | 2.15992236 |
| 88 | Progressive muscle weakness (HP:0003323) | 2.14620105 |
| 89 | Mitochondrial inheritance (HP:0001427) | 2.13390002 |
| 90 | Supernumerary ribs (HP:0005815) | 2.13247560 |
| 91 | Abnormality of the pons (HP:0007361) | 2.13206354 |
| 92 | Missing ribs (HP:0000921) | 2.13111329 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11027632 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11027632 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11027632 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.09759638 |
| 97 | Neoplasm of striated muscle (HP:0009728) | 2.08968823 |
| 98 | Shoulder girdle muscle weakness (HP:0003547) | 2.08635122 |
| 99 | Nasal polyposis (HP:0100582) | 2.07840930 |
| 100 | Bowel diverticulosis (HP:0005222) | 2.07402801 |
| 101 | Seborrheic dermatitis (HP:0001051) | 2.06989610 |
| 102 | Neoplasm of the rectum (HP:0100743) | 2.06775882 |
| 103 | Recurrent viral infections (HP:0004429) | 2.06625516 |
| 104 | Type II lissencephaly (HP:0007260) | 2.05118855 |
| 105 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.05049820 |
| 106 | Pointed chin (HP:0000307) | 2.04314460 |
| 107 | Abnormal biliary tract morphology (HP:0012440) | 2.02374965 |
| 108 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.02293732 |
| 109 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.02293732 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01396558 |
| 111 | 11 pairs of ribs (HP:0000878) | 2.01389422 |
| 112 | Truncus arteriosus (HP:0001660) | 1.99723194 |
| 113 | Squamous cell carcinoma (HP:0002860) | 1.98851911 |
| 114 | Adenoma sebaceum (HP:0009720) | 1.98584683 |
| 115 | Angiofibromas (HP:0010615) | 1.98584683 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 1.98482588 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98023702 |
| 118 | Cholecystitis (HP:0001082) | 1.97105161 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 1.97105161 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96446573 |
| 121 | Partial duplication of thumb phalanx (HP:0009944) | 1.95655590 |
| 122 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95445921 |
| 123 | Dicarboxylic aciduria (HP:0003215) | 1.95445921 |
| 124 | Agnosia (HP:0010524) | 1.95008267 |
| 125 | High pitched voice (HP:0001620) | 1.94801093 |
| 126 | Leukocytosis (HP:0001974) | 1.94117174 |
| 127 | Abnormal neuron morphology (HP:0012757) | 1.93941279 |
| 128 | Abnormality of the motor neurons (HP:0002450) | 1.93941279 |
| 129 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.92251431 |
| 130 | Chest pain (HP:0100749) | 1.92230360 |
| 131 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92113916 |
| 132 | Elfin facies (HP:0004428) | 1.91984618 |
| 133 | Abnormality of T cells (HP:0002843) | 1.91524343 |
| 134 | Lymphopenia (HP:0001888) | 1.91377488 |
| 135 | Renovascular hypertension (HP:0100817) | 1.90777014 |
| 136 | Prominent nose (HP:0000448) | 1.90026642 |
| 137 | Colitis (HP:0002583) | 1.87796375 |
| 138 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87682690 |
| 139 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.87323729 |
| 140 | Vacuolated lymphocytes (HP:0001922) | 1.86626216 |
| 141 | Neoplasm of the colon (HP:0100273) | 1.86613669 |
| 142 | Cellulitis (HP:0100658) | 1.86443706 |
| 143 | Acute hepatic failure (HP:0006554) | 1.85172641 |
| 144 | Microretrognathia (HP:0000308) | 1.85153659 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.84290139 |
| 146 | Abnormality of abdominal situs (HP:0011620) | 1.82239769 |
| 147 | Abdominal situs inversus (HP:0003363) | 1.82239769 |
| 148 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.81765547 |
| 149 | Difficulty climbing stairs (HP:0003551) | 1.81642013 |
| 150 | Unsteady gait (HP:0002317) | 1.80337453 |
| 151 | Abnormal number of erythroid precursors (HP:0012131) | 1.79939158 |
| 152 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79920565 |
| 153 | Thoracic kyphosis (HP:0002942) | 1.79603401 |
| 154 | Overriding aorta (HP:0002623) | 1.78870204 |
| 155 | Oral leukoplakia (HP:0002745) | 1.78776104 |
| 156 | Bundle branch block (HP:0011710) | 1.78623286 |
| 157 | Hyperthyroidism (HP:0000836) | 1.78311445 |
| 158 | Pallor (HP:0000980) | 1.77536962 |
| 159 | Neoplasm of the oral cavity (HP:0100649) | 1.76944597 |
| 160 | Abnormality of the thoracic spine (HP:0100711) | 1.76535518 |
| 161 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.76217319 |
| 162 | Hypoplasia of the brainstem (HP:0002365) | 1.76217319 |
| 163 | Rhabdomyosarcoma (HP:0002859) | 1.75757140 |
| 164 | Cafe-au-lait spot (HP:0000957) | 1.75653015 |
| 165 | Reticulocytopenia (HP:0001896) | 1.75354688 |
| 166 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.74999447 |
| 167 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.74999447 |
| 168 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74864726 |
| 169 | Urticaria (HP:0001025) | 1.74096290 |
| 170 | Acute lymphatic leukemia (HP:0006721) | 1.73019345 |
| 171 | Limb-girdle muscle atrophy (HP:0003797) | 1.70510881 |
| 172 | Tracheoesophageal fistula (HP:0002575) | 1.68593186 |
| 173 | Resting tremor (HP:0002322) | 1.68541388 |
| 174 | Ovarian neoplasm (HP:0100615) | 1.68515517 |
| 175 | Congenital hip dislocation (HP:0001374) | 1.68346763 |
| 176 | Bone marrow hypocellularity (HP:0005528) | 1.68048703 |
| 177 | Broad palm (HP:0001169) | 1.65027616 |
| 178 | Ankle clonus (HP:0011448) | 1.64987798 |
| 179 | Maternal diabetes (HP:0009800) | 1.64676981 |
| 180 | Short phalanx of the thumb (HP:0009660) | 1.64607152 |
| 181 | Neoplasm of the small intestine (HP:0100833) | 1.63244836 |
| 182 | Short 4th metacarpal (HP:0010044) | 1.62777724 |
| 183 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.62777724 |
| 184 | Severe visual impairment (HP:0001141) | 1.62668837 |
| 185 | Progressive microcephaly (HP:0000253) | 1.62639819 |
| 186 | Facial cleft (HP:0002006) | 1.62257139 |
| 187 | CNS hypomyelination (HP:0003429) | 1.61588337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.37550376 |
| 2 | NEK1 | 3.23627807 |
| 3 | BUB1 | 3.08356238 |
| 4 | CDC7 | 3.08097648 |
| 5 | MAP3K11 | 2.99654444 |
| 6 | KDR | 2.94088723 |
| 7 | PRKD3 | 2.74348001 |
| 8 | EEF2K | 2.69020600 |
| 9 | NEK2 | 2.63505326 |
| 10 | TSSK6 | 2.57419281 |
| 11 | PASK | 2.53409487 |
| 12 | PIM2 | 2.52765412 |
| 13 | TRIB3 | 2.42918560 |
| 14 | TESK2 | 2.37460725 |
| 15 | EIF2AK3 | 2.29513490 |
| 16 | MAP4K2 | 2.16303866 |
| 17 | SMG1 | 2.11699974 |
| 18 | WEE1 | 1.97785619 |
| 19 | FES | 1.94060252 |
| 20 | RPS6KB2 | 1.93117508 |
| 21 | MAP3K10 | 1.92834953 |
| 22 | VRK2 | 1.87347675 |
| 23 | ICK | 1.86965602 |
| 24 | PKN2 | 1.85009208 |
| 25 | CCNB1 | 1.78169170 |
| 26 | FLT3 | 1.77667259 |
| 27 | ARAF | 1.71079538 |
| 28 | RIPK4 | 1.68780282 |
| 29 | MAP3K4 | 1.65575501 |
| 30 | ERN1 | 1.63255849 |
| 31 | PDK3 | 1.63130034 |
| 32 | PDK4 | 1.63130034 |
| 33 | TESK1 | 1.59816246 |
| 34 | MAP2K3 | 1.56600892 |
| 35 | TTK | 1.52034531 |
| 36 | SIK2 | 1.50715960 |
| 37 | EIF2AK1 | 1.49796362 |
| 38 | TAOK2 | 1.45334463 |
| 39 | TBK1 | 1.44569729 |
| 40 | PLK1 | 1.37890751 |
| 41 | BRD4 | 1.37121360 |
| 42 | ATR | 1.36343287 |
| 43 | CSF1R | 1.35725928 |
| 44 | TNK2 | 1.33589862 |
| 45 | JAK3 | 1.28943834 |
| 46 | NME2 | 1.28629545 |
| 47 | PRPF4B | 1.26945041 |
| 48 | MAP4K1 | 1.23950698 |
| 49 | ALK | 1.17713326 |
| 50 | SCYL2 | 1.17466338 |
| 51 | PAK4 | 1.13113457 |
| 52 | CHEK1 | 1.10101196 |
| 53 | GRK7 | 1.08492189 |
| 54 | LIMK1 | 1.08296472 |
| 55 | STK38L | 1.06123148 |
| 56 | MTOR | 1.04755065 |
| 57 | TXK | 1.04042995 |
| 58 | DYRK2 | 1.03648613 |
| 59 | CDK7 | 1.03637165 |
| 60 | SRPK1 | 1.03486398 |
| 61 | DYRK3 | 1.02776519 |
| 62 | PRKCI | 1.01061338 |
| 63 | EPHA2 | 1.00673520 |
| 64 | MAP3K1 | 1.00003513 |
| 65 | BRSK1 | 0.99253725 |
| 66 | SYK | 0.98415041 |
| 67 | ZAK | 0.95327339 |
| 68 | STK10 | 0.94333982 |
| 69 | MAP2K7 | 0.94258076 |
| 70 | IKBKE | 0.93720391 |
| 71 | AURKB | 0.92505707 |
| 72 | CHEK2 | 0.89265299 |
| 73 | STK38 | 0.89068006 |
| 74 | BMX | 0.88831314 |
| 75 | NME1 | 0.88671104 |
| 76 | CDK4 | 0.87343183 |
| 77 | GRK6 | 0.84248031 |
| 78 | CDK2 | 0.84091758 |
| 79 | IRAK4 | 0.83965535 |
| 80 | LRRK2 | 0.83917612 |
| 81 | FGR | 0.83555195 |
| 82 | MAP3K5 | 0.83313769 |
| 83 | TAOK1 | 0.82417794 |
| 84 | BCKDK | 0.82145018 |
| 85 | BTK | 0.81258997 |
| 86 | CDK19 | 0.79130797 |
| 87 | PNCK | 0.77433337 |
| 88 | IKBKB | 0.77255136 |
| 89 | ITK | 0.76827200 |
| 90 | AURKA | 0.75829771 |
| 91 | MAP3K3 | 0.75718786 |
| 92 | LCK | 0.75194486 |
| 93 | ADRBK2 | 0.72952311 |
| 94 | ZAP70 | 0.72360636 |
| 95 | PLK3 | 0.72223467 |
| 96 | IRAK3 | 0.71950398 |
| 97 | PRKCQ | 0.71922098 |
| 98 | KSR1 | 0.70028903 |
| 99 | AKT3 | 0.69963801 |
| 100 | PAK2 | 0.69790622 |
| 101 | LYN | 0.68140152 |
| 102 | MAPKAPK3 | 0.67782701 |
| 103 | DAPK1 | 0.66555181 |
| 104 | PIM1 | 0.66279284 |
| 105 | PAK1 | 0.66002192 |
| 106 | DAPK3 | 0.65338648 |
| 107 | TLK1 | 0.65221201 |
| 108 | SIK3 | 0.63641014 |
| 109 | PAK6 | 0.63480079 |
| 110 | CSK | 0.62890696 |
| 111 | CDK18 | 0.62849335 |
| 112 | RPS6KA5 | 0.61683513 |
| 113 | SIK1 | 0.61384800 |
| 114 | MAP3K8 | 0.61177595 |
| 115 | RIPK1 | 0.61156112 |
| 116 | CDK15 | 0.60585208 |
| 117 | CDK11A | 0.60024106 |
| 118 | MAPK12 | 0.58557577 |
| 119 | PRKD2 | 0.57432672 |
| 120 | ATM | 0.56827104 |
| 121 | ABL2 | 0.56824734 |
| 122 | HCK | 0.54967443 |
| 123 | CDK1 | 0.54111583 |
| 124 | RPS6KC1 | 0.53900827 |
| 125 | RPS6KL1 | 0.53900827 |
| 126 | MAP2K2 | 0.52565286 |
| 127 | CAMKK1 | 0.50903988 |
| 128 | CAMK1D | 0.50887135 |
| 129 | GRK5 | 0.49356774 |
| 130 | STK16 | 0.46496692 |
| 131 | IRAK2 | 0.45798575 |
| 132 | MARK2 | 0.45689320 |
| 133 | LATS2 | 0.45065696 |
| 134 | CDC42BPA | 0.44927046 |
| 135 | RPS6KA6 | 0.44529051 |
| 136 | CSNK1E | 0.44424907 |
| 137 | CDK14 | 0.42864652 |
| 138 | MAPK11 | 0.41930987 |
| 139 | DYRK1B | 0.41871657 |
| 140 | CSNK1G3 | 0.41088362 |
| 141 | CDK3 | 0.40059826 |
| 142 | RPS6KA2 | 0.39571385 |
| 143 | TTN | 0.38606986 |
| 144 | KIT | 0.37773618 |
| 145 | BRAF | 0.37573594 |
| 146 | EPHA3 | 0.36313831 |
| 147 | CSNK2A2 | 0.35793218 |
| 148 | MAP2K4 | 0.35746621 |
| 149 | PRKCH | 0.35397458 |
| 150 | JAK2 | 0.34427109 |
| 151 | RPS6KA1 | 0.31572478 |
| 152 | MAPK14 | 0.31375523 |
| 153 | PDK2 | 0.31120144 |
| 154 | PDK1 | 0.31010950 |
| 155 | ACVR1B | 0.30511500 |
| 156 | MAPK15 | 0.30383824 |
| 157 | FYN | 0.30173882 |
| 158 | MAP3K9 | 0.29852236 |
| 159 | RPS6KA4 | 0.29120352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 4.01858980 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.41266860 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.14809315 |
| 4 | Spliceosome_Homo sapiens_hsa03040 | 3.11429199 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.05094729 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.84779624 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.64215632 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.36248667 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.33448249 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.25614337 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.16953211 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13415513 |
| 13 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.09263836 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.91341879 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81518408 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.76615295 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74937361 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.74180969 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71282120 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69574815 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.67129098 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.65462096 |
| 23 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60095913 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58246572 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54627441 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54620866 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.49575398 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47063764 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.46291487 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45588693 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.44819717 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42483576 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.42303741 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.40657226 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.38724885 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37785079 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36227324 |
| 38 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.36014106 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34944740 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34552937 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30127476 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.28525651 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28014133 |
| 44 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.26175033 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26150883 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25533387 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23022376 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22402369 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20827200 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19767133 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.14195508 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.11458319 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11328900 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10896111 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 1.10312406 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09004237 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08225507 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06428457 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01696057 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01319130 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01286190 |
| 62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00133922 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99730939 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98471166 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98395022 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97411869 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97299715 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.95534866 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92145292 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92060269 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91979854 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89149677 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88608294 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86332817 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.85134763 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83022890 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81281627 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.81122680 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79601366 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76994499 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76487954 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.72938213 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72498393 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71339668 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70671386 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.68292917 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67907027 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65813534 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.65628164 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64922850 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64916373 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64723225 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64173162 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64116543 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63005971 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62226378 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59994146 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58882915 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57618702 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57377602 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57346976 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55960228 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54736250 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54665407 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54168247 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54023675 |
| 107 | Insulin secretion_Homo sapiens_hsa04911 | 0.53692361 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53557154 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52486830 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.52247179 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51687010 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51456091 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51208095 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50825407 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49748401 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48792835 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47731707 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47206193 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46163313 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45570149 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45527032 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.44839996 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.44674988 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44037531 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43120665 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40762255 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.40648583 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39993587 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39267981 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.38859814 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38707681 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36721913 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36345908 |
| 134 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35901519 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.35637785 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35210647 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.35120745 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34746626 |
| 139 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34473938 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32077935 |
| 141 | Influenza A_Homo sapiens_hsa05164 | 0.31485260 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29635936 |
| 143 | Apoptosis_Homo sapiens_hsa04210 | 0.29284164 |
| 144 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28494256 |
| 145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28307726 |
| 146 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26785952 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26703943 |
| 148 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26589899 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26146150 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25732450 |
| 151 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.25421669 |
| 152 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25179915 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25004152 |

